Identifying Dopamine Transporter Regulator Proteins in C. elegans

鉴定秀丽隐杆线虫中的多巴胺转运蛋白调节蛋白

• 批准号: 7502703
• 负责人: SHANNON L HARDIE
• 金额: $ 1.28万
• 依托单位: VANDERBILT UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-08-13 至 2008-11-12
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7502703
• 关键词: Acute; Adopted; Alleles; Anabolism; Animal Model; Animals; Biochemical; Biogenic Amines; Biological Models; Brain; Caenorhabditis elegans; Candidate Disease Gene; Catecholamines; Chromosome Pairing; Co-Immunoprecipitations; Complex; Data; Disease; Dopamine; Drug Addiction; Ensure; Etiology; Felis catus; Fluorescence Microscopy; Functional disorder; Gene Expression; Genes; Genetic; Genetic Complementation Test; Genetic Screening; Genome; Goals; Green Fluorescent Proteins; Homeostasis; Invertebrates; Laboratories; Lead; Life; Mediating; Methods; Mixed Function Oxygenases; Modeling; Molecular; Morphology; Motor; Mutation; Nematoda; Nerve; Nervous system structure; Neuraxis; Neurons; Neurotoxins; Numbers; Orthologous Gene; Paralysed; Parkinson Disease; Pharmaceutical Preparations; Phenocopy; Phenotype; Population; Preparation; Process; Proteins; Proteomics; RNA Interference; Regulation; Reporting; Research; Research Training; Reserpine; Resistance; Schizophrenia; Signal Transduction; Single Nucleotide Polymorphism Map; Synapses; System; Techniques; Training; Transgenes; Transgenic Organisms; Yeasts; base; design; dopamine transporter; dopaminergic neuron; genetic analysis; genetic manipulation; genome sequencing; in vivo; inhibitor/antagonist; insight; interest; knockout animal; man; mutant; neuropsychiatry; neurotransmission; novel; presynaptic; promoter; psychostimulant; therapy development; tool; uptake; vesicular monoamine transporter 2; yeast two hybrid system

DESCRIPTION (provided by applicant): The goal of this study is to identify proteins involved in maintaining the regulated activity and localization of the dopamine (DA) transporter (DAT) at presynaptic nerve terminals. DA is a modulator of both excitatory and inhibitory neurotransmission in the CNS and is critically involved in the pathophysiology of several neuropsychiatric diseases including drug addiction and schizophrenia. DAT is a major determinant of synaptic DA inactivation, an important target for psychostimulant drugs, and a gateway for several neurotoxins. The proper expression and activity of DAT is therefore essential in maintaining normal DA homeostasis in the brain. DATs are subject to acute regulation and are known to form complexes with accessory proteins to control localization and activity, but the mechanisms mediating these processes m vivo are largely unknown. Further, though numerous studies have identified proteins that associate with DAT, no reports to date have demonstrated a functional relevance for these interactions. The intricacy of the mammalian CNS has encouraged our laboratory to pursue such questions in Caenorhabditis elegans. The high degree of conservation between invertebrate and vertebrate neurons at the molecular level suggests that analysis of the C. elegans DAT in living DA neurons could lead to novel insights of general relevance for DAT regulatory processes and DAT-supported drug addiction in man. In this proposal, I present two strategies for the identification of DAT-interacting proteins: first, I will employ RNA-based interference (RNAi) to disrupt the expression of orthologs that have been identified as putative DAT regulators; second, using a novel motor phenotype that I have identified and characterized, I will implement an unbiased, forward genetic screen. C. elegans offers considerable advantages over more complex vertebrate model systems, which make the nematode a valuable tool for identifying DAT-interacting proteins while simultaneously examining their functional relevance. The studies included in this proposal will serve as an excellent vehicle with which to advance my training in model systems genetics and DA neurotransmission and are an ideal avenue for my transition into research independence. Public: Alterations in dopaminergic (DA) neurotransmission are centrally involved in the pathophysiology of several neuropsychiatric diseases, including Parkinson's Disease, Schizophrenia, and drug addiction. Uptake via the presynaptic DA transporter (DAT) is the primary mechanism by which DA signaling at the synapse is terminated, and a thorough understanding of the processes that regulate DAT activity are critical in interpreting the etiology and progression of DA-related diseases. This research will define mechanisms that regulate DAT activity and will aid in the development of treatments for these diseases.

描述（由申请人提供）：本研究的目的是鉴定参与维持突触前神经末梢多巴胺（DA）转运蛋白（DAT）调节活性和定位的蛋白质。DA是CNS中兴奋性和抑制性神经传递的调节剂，并且在包括药物成瘾和精神分裂症在内的几种神经精神疾病的病理生理学中起关键作用。DAT是突触DA失活的主要决定因素，是精神兴奋剂药物的重要靶点，也是几种神经毒素的通道。因此，DAT的适当表达和活性对于维持脑中正常DA稳态至关重要。DAT受到急性调节，并且已知与辅助蛋白形成复合物以控制定位和活性，但体内介导这些过程的机制在很大程度上是未知的。此外，尽管许多研究已经鉴定了与DAT相关的蛋白质，但迄今为止还没有报告证明这些相互作用的功能相关性。哺乳动物中枢神经系统的复杂性鼓励我们的实验室在秀丽隐杆线虫中探索这些问题。无脊椎动物和脊椎动物神经元在分子水平上的高度保守性表明，对C。本论文提出了两种鉴定DAT相互作用蛋白的策略：第一，利用RNA干扰技术（RNAi）干扰DAT调控蛋白的表达;第二，使用我已经鉴定和表征的新的运动表型，我将实施无偏见的向前遗传筛选。C.线虫提供了比更复杂的脊椎动物模型系统更大的优势，这使得线虫成为鉴定DAT相互作用蛋白同时检查其功能相关性的有价值的工具。本提案中包含的研究将作为一个很好的工具，促进我在模型系统遗传学和DA神经传递方面的培训，也是我过渡到研究独立性的理想途径。公众：多巴胺能（DA）神经传递的改变主要涉及几种神经精神疾病的病理生理学，包括帕金森病，精神分裂症和药物成瘾。通过突触前DA转运蛋白（DAT）的摄取是DA信号在突触处终止的主要机制，并且对调节DAT活性的过程的透彻理解对于解释DA相关疾病的病因和进展至关重要。这项研究将确定调节DAT活性的机制，并有助于开发这些疾病的治疗方法。